Targeting autophagy overcomes enzalutamide resistance in castrate-resistant prostate cancer cells and improves therapeutic response in a xenograft model

被引：0
|
作者：
Yang, Joy C. [1 ]
Nguyen, Hao G. [2 ]
Kung, Hsing-Jien [1 ]
Shi, Xu-Bao [1 ]
Tilki, Derya [1 ]
White, Ralph W. deVere [1 ]
Gao, Allen C. [1 ]
Evans, Christopher P. [1 ]
机构：
[1] UC Davis Med Ctr, Sacramento, CA USA
[2] UCSF Med Ctr, San Francisco, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
327
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer
    Won, Andy C. M.
    Gurney, Howard
    Marx, Gavin
    De Souza, Paul
    Patel, Manish I.
    BJU INTERNATIONAL, 2013, 112 (04) : E250 - E255
  • [42] Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
    Ashrafi, Akbar N.
    Fay, Carlos
    Yip, Wesley
    de Freitas, Daniel M.
    Nabhani, Jamal
    Aron, Monish
    UROLOGY CASE REPORTS, 2020, 32
  • [43] Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
    Nunes, Jessica J.
    Pandey, Swaroop K.
    Yadav, Anjali
    Goel, Sakshi
    Ateeq, Bushra
    NEOPLASIA, 2017, 19 (04): : 333 - 345
  • [44] Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer
    Zhang, I.
    Gilbo, P.
    Cox, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E530 - E530
  • [45] A Validated Prognostic Index Predicting Response to Dexamethasone and Diethylstilbestrol in Castrate-Resistant Prostate Cancer
    Shamash, Jonathan
    Stebbing, Justin
    Sweeney, Chris
    Sonpavde, Guru
    Harland, Steve
    Dawkins, Guy
    Brock, Cathryn
    Abelman, Walter
    Wilson, Peter
    Sanitt, Adam
    Oliver, Tim
    Powles, Thomas
    CANCER, 2010, 116 (15) : 3595 - 3602
  • [46] Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide
    Haas, Naomi B.
    LaRiviere, Michael J.
    Buckingham, Thomas H.
    Cherkas, Yauheniya
    Calara-Nielsen, Karl
    Foulk, Brad
    Patel, Jaymala
    Gross, Steven
    Smirnov, Denis
    Vaughn, David J.
    Amaravadi, Ravi
    Wellen, Kathryn E.
    Savitch, Samantha L.
    Majmundar, Krishna J.
    Black, Taylor A.
    Yee, Stephanie S.
    He, Miaoling
    Min, Eun Jeong
    Long, Qi
    Jones, Jeremy O.
    Pal, Sumanta K.
    Carpenter, Erica L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (02) : 448 - 456
  • [47] Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature.
    Lariviere, Michael Joseph
    Haas, Naomi B.
    Cherkas, Yauheniya
    Nielsen, Karl
    Foulk, Brad
    Patel, Jaymala
    Smirnov, Denis
    Vaughn, David J.
    Amaravadi, Ravi K.
    Savitch, Samantha L.
    Majmundar, Krishna
    Buckingham, Thomas H.
    Yee, Stephanie S.
    Jones, Jeremy
    Pal, Sumanta K.
    Carpenter, Erica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Stem cells in prostate cancer - Resolving the castrate-resistant conundrum and implications for hormonal therapy
    Sharifi, Nima
    Kawasaki, Brian I.
    Hurt, Elaine M.
    Farrar, William L.
    CANCER BIOLOGY & THERAPY, 2006, 5 (08) : 901 - 906
  • [49] Androgen Receptor Antagonism by Divalent Ethisterone Conjugates in Castrate-Resistant Prostate Cancer Cells
    Levine, Paul M.
    Lee, Eugine
    Greenfield, Alex
    Bonneau, Richard
    Logan, Susan K.
    Garabedian, Michael J.
    Kirshenbaum, Kent
    ACS CHEMICAL BIOLOGY, 2012, 7 (10) : 1693 - 1701
  • [50] Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide
    Naomi B. Haas
    Michael J. LaRiviere
    Thomas H. Buckingham
    Yauheniya Cherkas
    Karl Calara-Nielsen
    Brad Foulk
    Jaymala Patel
    Steven Gross
    Denis Smirnov
    David J. Vaughn
    Ravi Amaravadi
    Kathryn E. Wellen
    Samantha L. Savitch
    Krishna J. Majmundar
    Taylor A. Black
    Stephanie S. Yee
    Miaoling He
    Eun Jeong Min
    Qi Long
    Jeremy O. Jones
    Sumanta K. Pal
    Erica L. Carpenter
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 448 - 456
12345